Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-09-01Clinical Trial Update: Inflammatory Markers and Adverse Outcomes in Chronic Kidney Disease
A completed clinical trial investigating the relationship between inflammatory markers and adverse outcomes in chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Exercise and Vascular Function in Chronic Kidney Disease [Phase 4]
A Phase 4 clinical trial assessing the impact of exercise on vascular function in chronic kidney disease has completed. The sponsor is the U…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Acid-Base Compensation in Chronic Kidney Disease [Phase 1]
A Phase 1 trial evaluating acid-base compensation in chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: The Effect of a Renal Specific Oral Nutritional Supplement on Nutritional Status [NA]
A completed clinical trial assessing the impact of a renal-specific oral nutritional supplement on nutritional status in chronic kidney dise…
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With Atrasentan [Phase 2]
Phase 2 trial evaluating atrasentan to reduce residual albuminuria in people with diabetes and nephropathy has completed. The results may in…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Impact of Increased Water Intake in Chronic Kidney Disease [NA]
A clinical trial investigated the impact of increased water intake on individuals with chronic kidney disease and the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease [Phase 3]
Phase 3 trial evaluating FG-4592 (roxadustat) for anemia in chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Evaluating the Role of Cystatin C and Creatinine as Markers of Renal Recovery in Critically Ill Patients After Acute Kidney Injury.
This completed trial from Karolinska Institutet evaluated whether cystatin C and creatinine can serve as biomarkers of renal recovery in cri…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis [Phase 2]
Deltanoid's oral vitamin D compound DP001 completed a Phase 2 study evaluating its effects in secondary hyperparathyroidism among patients o…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Cognitive Impairment in Kidney Disease
A clinical trial investigating cognitive impairment in people with chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Observational Study of Kibow Biotics in Chronic Kidney Failure Patients
An observational study evaluating Kibow Biotics in patients with chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Vitamin D and Arterial Function in Patients With Chronic Kidney Disease [Phase 3]
Phase 3 trial investigating vitamin D and arterial function in adults with chronic kidney disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-17Clinical Trial Update: Clinical Study of Asahi ViE Dialyzer in Canada [NA]
Clinical study of the Asahi ViE Dialyzer in Canada has completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-08-15Clinical Trial Update: Intervention to Reduce Dietary Sodium in Hemodialysis [NA]
A completed clinical trial from the University of Pittsburgh evaluated reducing dietary sodium in patients on hemodialysis; results were pos…
-
FDA approval · 2017-08-11FDA Approved: LANTHANUM CARBONATE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' generic lantHanum carbonate under an original ANDA to treat hyperphosphatemia in adults with end-stage r…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism [Phase 2]
Phase 2 trial evaluating safety and tolerability of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyr…
-
CLINICAL_TRIALS trial_result · 2017-08-11Clinical Trial Update: Medication Adherence in Kidney Transplant Recipients Using Automated Reminders and Provider Notification [NA]
This clinical trial evaluated automated reminders and provider notifications to improve medication adherence in kidney transplant recipients…
-
CLINICAL_TRIALS research · 2017-08-11Clinical Trial Update: Screening and Assessing the Risk Factors and Complications of Chronic Kidney Disease
This clinical trial update describes a study conducted by Chinese PLA General Hospital to screen for and evaluate risk factors and complicat…
-
CLINICAL_TRIALS research · 2017-08-11Clinical Trial Update: Chinese Observational Prospective Study of Aging Population With Chronic Kidney Disease(C-OPTION)
An observational prospective study in aging individuals with chronic kidney disease conducted in China. Sponsored by Chinese PLA General Hos…
-
CLINICAL_TRIALS research · 2017-08-10Clinical Trial Update: Morphological Changes of the Brain by MRI in Chronic Kidney Disease
A clinical trial update examining morphological changes in the brain using MRI in patients with chronic kidney disease requiring chronic dia…
-
CLINICAL_TRIALS trial_result · 2017-08-09Clinical Trial Update: Renal Sympathetic Denervation in Moderate to Severe Chronic Kidney Disease [NA]
Clinical trial update indicates that a study of renal sympathetic denervation in patients with hypertension and chronic kidney disease has c…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: HeRO Vascular Access Device Bacteremia Study [NA]
This entry reports a completed clinical trial evaluating the HeRO Vascular Access Device for reducing bacteremia in patients undergoing hemo…
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen [Phase 2]
Open-label Phase 2 trial evaluating a steroid-free, calcineurin inhibitor–free, belatacept-based immunosuppressive regimen in kidney transpl…
-
CLINICAL_TRIALS withdrawal · 2017-08-07Clinical Trial Update: Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients [NA]
Clinical trial evaluating everolimus (Zortress) plus tacrolimus versus standard immunosuppression in de novo renal transplant recipients, fo…
-
FDA label_change · 2017-08-03FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)
FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) to update the product labeling.